Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study

BACKGROUND: Since 2007 biosimilars of erythropoiesis-stimulating agents (ESAs) are available on the Italian market. Very limited post-marketing data exist on the comparative effectiveness of biosimilar and originator ESAs. AIM: This population-based study was aimed to compare the effects of biosimil...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:PLoS One
Κύριοι συγγραφείς: Ingrasciotta, Ylenia, Giorgianni, Francesco, Marcianò, Ilaria, Bolcato, Jenny, Pirolo, Roberta, Chinellato, Alessandro, Ientile, Valentina, Santoro, Domenico, Genazzani, Armando A., Alibrandi, Angela, Fontana, Andrea, Caputi, Achille P., Trifirò, Gianluca
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Public Library of Science 2016
Θέματα:
Research Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4871488/
https://ncbi.nlm.nih.gov/pubmed/27187174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0155805
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια